Pharma Journalist - Page 71 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Genezen and Optieum Partner to Advance cGMP Manufacturing for Glioblastoma CAR-T Therapy

Adcentrx’s ADRX-0706 Nectin-4 ADC Earns FDA Fast Track for Advanced Cervical Cancer

Opus Genetics’ OPGx-LCA5 Gene Therapy Earns FDA RMAT Designation

BioVaxys and Sona Nanotech Enter Research Collaboration

Speaker Interview with Anna Karmann, Chief Medical Officer, AdvanCell

FDA Grants Fast Track for Alterity’s ATH434 in Multiple System Atrophy Treatment

Oral Semaglutide 25 mg Filing Accepted by FDA; Could Be First Oral GLP-1 for Obesity

TAE Life Sciences and Ohio State Partner on Boron Drug Innovation for Cancer Therapy

Teva and Alvotech Gain FDA Interchangeability for SELARSDI Biosimilar to Stelara

VERAXA and OmniAb Partner to Develop Novel Bispecific Antibody-Drug Conjugate